News Takeda finalises buyout of TiGenix Japanese pharma giant Takeda has completed its buyout of TiGenix.
News Takeda to buy stem cell specialists TiGenix for $626m Decision follows EU regulators' decision to back Crohn's stem cell therapy
News First ever 'off the shelf' stem cell therapy nears European ... Alofisel recommended for complex perianal fistulas in Crohn's disease
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
